<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" nameag="viewport"/>
<title>Antiepileptic Drugs</title>
<script src="https://cdn.tailwindcss.com"></script>
<script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
<script src="https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js"></script>
<style>
        /* Custom styles for enhanced aesthetics and responsiveness */
        .option-btn {
            transition: all 0.3s ease;
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
        }
        .option-btn:hover, .option-btn:active {
            transform: scale(1.02);
            box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
        }
        .option-btn.selected {
            background-color: #3b82f6;
            color: white;
        }
        .marked {
            background-color: #fef08a;
        }
        .progress-bar {
            transition: width 0.5s ease-in-out;
            background: linear-gradient(to right, #3b82f6, #22c55e);
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
            animation: pulse 2s infinite;
        }
        @keyframes pulse {
            0% { opacity: 1; }
            50% { opacity: 0.8; }
            100% { opacity: 1; }
        }
        .question-nav-btn, .result-nav-btn-grid {
            width: 40px;
            height: 40px;
            display: flex;
            align-items: center;
            justify-content: center;
            border-radius: 8px;
            font-size: 16px;
            touch-action: manipulation;
            transition: all 0.2s ease;
        }
        .question-nav-btn:hover, .question-nav-btn:active, .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
            transform: scale(1.05);
        }
        .answered {
            background-color: #22c55e;
            color: white;
        }
        .unanswered {
            background-color: #e5e7eb;
        }
        .marked-nav {
            border: 2px solid #fef08a;
        }
        .video-container, .audio-container {
            display: none;
            position: relative;
        }
        .video-container.active, .audio-container.active {
            display: block;
            animation: fadeIn 0.5s ease-in;
        }
        @keyframes fadeIn {
            from { opacity: 0; }
            to { opacity: 1; }
        }
        .section-transition {
            transition: opacity 0.3s ease;
        }
        .section-transition.hidden {
            opacity: 0;
            pointer-events: none;
        }
        .result-nav {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-top: 1rem;
        }
        .result-nav-btn {
            background-color: #4b5563;
            color: white;
            padding: 0.5rem 1rem;
            border-radius: 8px;
            transition: all 0.2s ease;
        }
        .result-nav-btn:hover, .result-nav-btn:active {
            background-color: #374151;
            transform: scale(1.05);
        }
        .result-nav-btn:disabled {
            background-color: #d1d5db;
            cursor: not-allowed;
        }
        .error-message {
            color: #dc2626;
            font-weight: bold;
            margin-top: 1rem;
        }
        /* Mobile-specific adjustments */
        @media (max-width: 640px) {
            .question-nav-btn, .result-nav-btn-grid {
                width: 38px;
                height: 38px;
                font-size: 14px;
            }
            .nav-panel, .results-nav-panel {
                width: 100%;
                max-width: 100%;
                overscroll-behavior: contain;
            }
            .option-btn {
                padding: 12px;
                font-size: 14px;
            }
            .header-text {
                font-size: 1.5rem;
            }
            .subheader-text {
                font-size: 0.875rem;
            }
            .button-group, .result-nav {
                flex-direction: column;
                gap: 0.5rem;
            }
            .result-nav-btn {
                width: 100%;
                text-align: center;
            }
        }
        /* Dark mode styles */
        .dark .bg-gray-100 {
            background-color: #1f2937;
        }
        .dark .bg-white {
            background-color: #374151;
        }
        .dark .text-gray-700 {
            color: #d1d5db;
        }
        .dark .text-gray-800 {
            color: #e5e7eb;
        }
        .dark .bg-gray-200 {
            background-color: #4b5563;
        }
        .dark .border {
            border-color: #4b5563;
        }
        .dark .bg-blue-500 {
            background-color: #2563eb;
        }
        .dark .hover\:bg-blue-600:hover {
            background-color: #1d4ed8;
        }
        .dark .bg-yellow-300 {
            background-color: #b45309;
            color: white;
        }
        .dark .hover\:bg-yellow-400:hover {
            background-color: #92400e;
        }
        .dark .bg-green-500 {
            background-color: #15803d;
        }
        .dark .hover\:bg-green-600:hover {
            background-color: #166534;
        }
        .dark .bg-gray-500 {
            background-color: #4b5563;
        }
        .dark .hover\:bg-gray-600:hover {
            background-color: #374151;
        }
        .dark .result-nav-btn, .dark .result-nav-btn-grid {
            background-color: #2563eb;
        }
        .dark .result-nav-btn:hover, .dark .result-nav-btn:active, .dark .result-nav-btn-grid:hover, .dark .result-nav-btn-grid:active {
            background-color: #1d4ed8;
        }
        .dark .result-nav-btn:disabled, .dark .result-nav-btn-grid:disabled {
            background-color: #4b5563;
        }
        .video-placeholder {
            width: 400px;
            height: 300px;
            background-color: #f0f0f0;
            display: flex;
            align-items: center;
            justify-content: center;
            cursor: pointer;
            margin-top: 10px;
            border-radius: 8px;
            border: 1px solid #ccc;
        }
        .play-icon {
            font-size: 40px;
            color: #007bff;
        }
        .video-loading {
            position: absolute;
            top: 50%;
            left: 50%;
            transform: translate(-50%, -50%);
            border: 4px solid #f3f3f3;
            border-top: 4px solid #3b82f6;
            border-radius: 50%;
            width: 40px;
            height: 40px;
            animation: spin 1s linear infinite;
        }
        @keyframes spin {
            0% { transform: translate(-50%, -50%) rotate(0deg); }
            100% { transform: translate(-50%, -50%) rotate(360deg); }
        }
    </style>

<script>
    // --- GEMINI AUTO-CAPTURE LISTENER ---
    // This function runs immediately after the quiz determines an answer is INCORRECT.
    function captureMistake(questionIndex, questionsData) {
        try {
            const item = questionsData[questionIndex];
            // Use the question text as a unique, stable identifier
            const uniqueId = 'srs_quiz_' + btoa(item.text.substring(0, 50)).replace(/=/g, ''); 

            // 1. Clean and simplify the explanation for storage
            let explanationText = item.explanation || item.correct_answer || "No explanation provided.";
            
            // Strip complex HTML (images, lists) and boilerplate text
            explanationText = explanationText.replace(/<img[^>]*>/g, "[IMAGE]").trim(); // Replace images with placeholder
            explanationText = explanationText.replace(/<p><strong>Ans\. [A-Z]\).*/i, "").trim(); // Remove the repeated Answer line
            explanationText = explanationText.replace(/<p><strong>Educational Objective:<\/strong>.*?<\/p>/gs, "").trim(); // Remove EO block
            explanationText = explanationText.replace(/@dams_new_robot/g, "");
            explanationText = explanationText.replace(/<\/?[^>]+(>|$)/g, " ").trim(); // Final strip of remaining tags

            // 2. Prepare card data
            const cardData = {
                text: item.text,
                answer: item.correct_answer,
                explanation: explanationText.substring(0, 500), // Keep explanations short
                nextReview: 0, // Due immediately
                reviews: 0,
                source: document.title.split('-')[0].trim() || 'Quiz'
            };

            // 3. Save to Local Storage (SRS Bank)
            localStorage.setItem(uniqueId, JSON.stringify(cardData));
            
            console.log(`ðŸ§  Captured Mistake #${questionIndex + 1} from ${document.title}`);

        } catch (e) {
            console.error("SRS Capture Failed:", e);
        }
    }
    // --- END GEMINI AUTO-CAPTURE LISTENER ---
</script>

</head>
<body class="bg-gray-100 font-sans transition-colors duration-300 min-h-screen overflow-y-auto">
<!-- Header Section -->
<header class="bg-blue-600 text-white p-4 shadow-lg">
<div class="container mx-auto">
<h1 class="text-2xl md:text-3xl font-bold header-text">Antiepileptic Drugs</h1>
<p class="mt-2 text-sm md:text-base subheader-text">
                14 Questions | 14 Total Marks | 24 min Duration | ~102.86 sec/question
            </p>
<button class="mt-2 bg-gray-200 text-gray-800 px-3 py-1 rounded-lg hover:bg-gray-300 transition dark:bg-gray-600 dark:text-white" id="theme-toggle">
                Toggle Dark Mode
            </button>
</div>
</header>
<!-- Instructions Section -->
<section class="container mx-auto p-4 md:p-6 section-transition" id="instructions">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-xl font-semibold mb-4">Instructions</h2>
<ul class="list-disc list-inside space-y-2 text-gray-700">
<li>This test contains 14 multiple choice questions.</li>
<li>Each question has only one correct answer.</li>
<li>You will have 24 minutes to complete the test.</li>
<li>Click or tap on an option to select your answer.</li>
<li>Use the "Mark for Review" button to revisit questions.</li>
<li>Navigate using Previous/Next buttons or the Questions Navigation panel.</li>
<li>Click "Submit" to finish and view results.</li>
<li>The test will auto-submit when time runs out.</li>
</ul>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="start-test">Start Test</button>


</div>
<div class="error-message hidden" id="error-message"></div>
</div>
</section>
<!-- Quiz Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="quiz">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<!-- Progress Bar -->
<div class="w-full bg-gray-200 rounded-full h-3 mb-4">
<div class="progress-bar h-3 rounded-full" id="progress-bar" style="width: 0%"></div>
</div>
<!-- Question Header -->
<div class="flex flex-col md:flex-row justify-between items-center mb-4">
<h2 class="text-lg font-semibold" id="question-number">Question <span>1</span> of 14</h2>
<p class="text-lg font-semibold mt-2 md:mt-0" id="timer">Time Remaining: <span>00:00</span></p>
</div>
<!-- Question Content -->
<div class="mb-6" id="question-content">
<p class="text-gray-800 mb-4" id="question-text"></p>
<div class="flex flex-wrap gap-4 mb-4" id="question-images"></div>
<div class="space-y-3" id="options"></div>
</div>
<!-- Navigation Buttons -->
<div class="flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition w-full md:w-auto" disabled="" id="previous-btn">Previous</button>
<button class="bg-yellow-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-yellow-400 transition w-full md:w-auto" id="mark-review">Mark for Review</button>
<button class="bg-blue-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="next-btn">Next</button>
<button class="bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full md:w-auto" id="nav-toggle">Questions Navigation</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="submit-test">Submit Test</button>
</div>
</div>
</section>
<!-- Results Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="results">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-2xl font-semibold mb-4">Antiepileptic Drugs - Results</h2>
<div class="grid grid-cols-1 md:grid-cols-2 gap-4 mb-6">
<p><strong>Correct:</strong> <span id="correct-count">0</span></p>
<p><strong>Wrong:</strong> <span id="wrong-count">0</span></p>
<p><strong>Unanswered:</strong> <span id="unanswered-count">0</span></p>
<p><strong>Marked for Review:</strong> <span id="marked-count">0</span></p>
</div>
<h3 class="text-lg font-semibold mb-4" id="result-question-number">Question <span>1</span> of 14</h3>
<div class="space-y-6" id="results-content"></div>
<div class="result-nav">
<button aria-label="Previous question result" class="result-nav-btn" disabled="" id="prev-result">Previous</button>
<button aria-label="Toggle results navigation panel" class="result-nav-btn" id="results-nav-toggle">Results Navigation</button>
<button aria-label="Next question result" class="result-nav-btn" id="next-result">Next</button>
</div>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="take-again">Take Again</button>
<button class="bg-gray-500 text-white px-6 py-2 rounded-lg hover:bg-gray-600 transition" id="review-test">Review Test</button>
</div>
</div>
</section>
<!-- Exit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="exit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Leave Test?</h2>
<p class="text-gray-700 mb-4">Your progress will be lost if you leave this page. Are you sure you want to exit?</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="continue-test">No, Continue</button>
<button class="bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition" id="exit-test">Yes, Exit</button>
</div>
</div>
</div>
<!-- Submit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="submit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Confirm Submission</h2>
<p class="text-gray-700 mb-2">You have attempted <span id="attempted-count">0</span> of 14 questions.</p>
<p class="text-gray-700 mb-4"><span id="unattempted-count">0</span> questions are unattempted.</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="cancel-submit">Cancel</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-green-600 transition" id="confirm-submit">Submit Test</button>
</div>
</div>
</div>
<!-- Quiz Navigation Panel -->
<div class="fixed inset-y-0 right-0 nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="nav-panel">
<h2 class="text-lg font-semibold mb-4">Questions Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-nav">Close</button>
</div>
<!-- Results Navigation Panel -->
<div class="fixed inset-y-0 right-0 results-nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="results-nav-panel">
<h2 class="text-lg font-semibold mb-4">Results Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="results-nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="results-nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-results-nav">Close</button>
</div>
<!-- JavaScript Logic -->
<script>
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog("Attempting to parse questions_json");
            questions = [{"text": "A 30-year-old male patient is admitted to the emergency department with symptoms of drowsiness and inattentiveness. He is a known epileptic and on treatment. His wife said the doctor recently increased the dose of antiepileptic to control seizures effectively. Examination by the treating physician reveals he has an ataxic gait and gum hypertrophy. Which antiepileptic is the patient taking?", "options": [{"label": "A", "text": "Phenytoin", "correct": true}, {"label": "B", "text": "Sodium valproate", "correct": false}, {"label": "C", "text": "Carbamazepine", "correct": false}, {"label": "D", "text": "Ethosuximide", "correct": false}], "correct_answer": "A. Phenytoin", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Phenytoin</p>\n<p><strong>Highyeild:</strong></p><p>Among the given options of antiepileptic drugs, phenytoin causes gum hypertrophy, and a high dose causes cerebellar symptoms like Ataxia and nystagmus. Phenytoin follows saturation kinetics, in which a constant quantity is eliminated per unit of time. A small increase in dose can result in a large increase in concentration and can result in toxicity. Therefore Phenytoin dosage should not be increased by more than 25- 30mg/day.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: B. Sodium valproate causes Anorexia, vomiting, loose motions, and common but mild heartburn. Drowsiness, ataxia, and tremor occur at high doses. Option: C. Carbamazepine produces dose-related neurotoxicityâ€”sedation, dizziness, vertigo, diplopia, and ataxia. But does not cause gum hypertrophy. Option: D. Ethosuximide causes Dose-related side effects - gastrointestinal intolerance, tiredness, mood changes, agitation, headache, drowsiness, and inability to concentrate</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A patient was put on carbamazepine for GTCS. His seizure episodes were controlled for one month. After one month, he had two episodes of seizures in two following weeks. The next best step is:", "options": [{"label": "A", "text": "Increase the dose of carbamazepine", "correct": true}, {"label": "B", "text": "Decrease the dose of carbamazepine", "correct": false}, {"label": "C", "text": "Shift to other anti-epileptic", "correct": false}, {"label": "D", "text": "Advised iv diazepam during episodes", "correct": false}], "correct_answer": "A. Increase the dose of carbamazepine", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Increase the dose of carbamazepine</p>\n<p><strong>:</strong></p><p>Carbamazepine is an enzyme inducer and undergoes auto-induction It induces its metabolism, causing its serum concentration to fall after a few weeks of treatment. The half-life, typically 36 hours after a single initial dose, falls to 8-12 hours in subjects who receive carbamazepine continuously. So in this patient, dose adjustments are required after a few weeks of treatment, and since the seizure is increased, increasing the dose of carbamazepine is the next best step.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: B, C, and D is the incorrect option</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 22-year-old female with GTCS is well controlled with tab phenytoin 300mg per day becomes pregnant. Pick the correct advice:", "options": [{"label": "A", "text": "Stop phenytoin plus start Phenobarbitone and Folic Acid", "correct": false}, {"label": "B", "text": "Stop phenytoin plus start lamotrigine and Folic Acid", "correct": false}, {"label": "C", "text": "Stop phenytoin and add tab Folic Acid", "correct": false}, {"label": "D", "text": "Continue with phenytoin and add a tab Folic Acid and during the last two weeks of pregnancy, give oral Vitamin K", "correct": true}], "correct_answer": "D. Continue with phenytoin and add a tab Folic Acid and during the last two weeks of pregnancy, give oral Vitamin K", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Continue with phenytoin and add a tab Folic Acid and during the last two weeks of pregnancy, give oral Vitamin K</p>\n<p><strong>Highyeild:</strong></p><p>Stopping phenytoin has more risk than continuing it So, guidelines say to continue the antiepileptic (phenytoin or valproate, etc.). The patient is well-controlled on phenytoin and adds folic acid as soon as pregnancy is detected (to decrease NTDS) Oral vitamin K is given to prevent bleeding episodes in newborns, as phenytoin causes vitamin K deficiency NOTE: If the patient is diagnosed with epilepsy during pregnancy and needs to start an antiepileptic drug, then start with the new lamotrigine, which has less NTDS & safer in pregnancy as compared to conventional antiepileptics. Folic acid supplementation should be continued</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: A . Stop phenytoin plus start Phenobarbitone and Folic Acid is the wrong advice Option: B. Stop phenytoin plus start lamotrigine and Folic Acid. Again wrong advice Option: C. Stop phenytoin, and adding a tab of Folic Acid is not advisable.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A patient is on long-term anticonvulsant therapy. There is progressive contractility of the visual field. The likely anti-epileptic drug responsible for this adverse effect is?", "options": [{"label": "A", "text": "Vigabatrin", "correct": true}, {"label": "B", "text": "Ethosuximide", "correct": false}, {"label": "C", "text": "Phenobarbital", "correct": false}, {"label": "D", "text": "Levetiracetam", "correct": false}], "correct_answer": "A. Vigabatrin", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Vigabatrin</p>\n<p><strong>:</strong></p><p>GABA transaminase inhibitor Used for partial seizures As orphan status for infantile spasms Infantile spasms due to tuberous sclerosis were particularly responsive to vigabatrin. Progressive and permanent bilateral vision loss occurs with vigabatrin. It is not used even though it is highly effective in infantile spasms. It is reserved in resistant cases.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Indication of other drugs: Option: B. Ethosuximide- Absence seizure Transient opening of type ca++ channel Petit mal seizure Option: C. Phenobarbital- GTCS Alcohol withdrawal Option: D. Levetiracetam- Used for partial-onset Myoclonic, Tonic-clonic seizures</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which of the following antiepileptic Mechanism Of Action is wrongly matched", "options": [{"label": "A", "text": "CRMP 2 inhibitors: lacosamide", "correct": false}, {"label": "B", "text": "SV2A Protein inhibitors: levetiracetam", "correct": false}, {"label": "C", "text": "Acting on K Channel: ezogabine", "correct": false}, {"label": "D", "text": "NMDA receptor antagonists: Topiramate", "correct": true}], "correct_answer": "D. NMDA receptor antagonists: Topiramate", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>NMDA receptor antagonists: Topiramate Acting on K Channel: Retigabine/ezogabine NMDA receptor antagonists Felbamate AMPA antagonist: Topiramate Lamotrigine Phenobarbitone CRMP 2 inhibitors: Lacosamide SV2A Protein inhibitors: Levetiracetam</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: A. CRMP 2 inhibitors: lacosamide is a correct match Option: B. SV2A Protein inhibitors: levetiracetam is a correct match Option: C. Acting on K Channel: ezogabine is a correct match</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "The therapeutic level of Carbamazepine is:", "options": [{"label": "A", "text": "10 â€“ 20 mg/L", "correct": false}, {"label": "B", "text": "4 - 12 mcg/mL", "correct": true}, {"label": "C", "text": "15 to 45 mg/", "correct": false}, {"label": "D", "text": "50 -100 mg/L", "correct": false}], "correct_answer": "B. 4 - 12 mcg/mL", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>4 - 12 mcg/mL</p>\n<p><strong>Highyeild:</strong></p><p>Sl no Drug Therapeutic level 1 Phenytoin 10-20 mcg/mL 2 Phenobarbitone 15-40 mcg/mL 3 Carbamazepine 4 - 12 mcg/mL 4 Levetiracetam 12 to 46 mcg/mL 5 Ethosuximi 40 to 100 mcg/mL 6 Lamotrigine 3-15 mcg/mL 7 Valproic acid 40-100 mcg/mL</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Systemic visual monitoring by an ophthalmic professional is required when a patient takes the following anti-epileptic drug:", "options": [{"label": "A", "text": "Perampanel", "correct": false}, {"label": "B", "text": "Ezogabine", "correct": true}, {"label": "C", "text": "Felbamate", "correct": false}, {"label": "D", "text": "Zonisamide", "correct": false}], "correct_answer": "B. Ezogabine", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Ezogabine</p>\n<p><strong>:</strong></p><p>Chronic treatment with ezogabine may cause retinal abnormalities FDA recommends that all patients taking ezogabine should have baseline and periodic (every six months) systemic visual monitoring by an ophthalmic professional, which includes both visual acuity and dilated fundus photography</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: A. Perampanel is an anti-epileptic medication developed by Eisai Co. that is used in addition to other drugs to treat partial seizures and generalized tonic-clonic seizures for people older than twelve years Option: C. Felbamate is an anticonvulsant used in the treatment of epilepsy. It treats partial seizures (with and without generalization) in adults and partial and generalized seizures associated with Lennoxâ€“Gastaut syndrome in children. Option: D. Zonisamide is a prescription medicine used with other medicines to treat and prevent epilepsy (seizures). It controls seizures by decreasing the abnormal and excessive activity of the nerve cells in the brain.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "In a child of infantile spasm with a visual defect, which drug is not used even though it is highly effective?", "options": [{"label": "A", "text": "Lamotrigine", "correct": false}, {"label": "B", "text": "Topiramate", "correct": false}, {"label": "C", "text": "ACTH", "correct": false}, {"label": "D", "text": "Vigabatrin", "correct": true}], "correct_answer": "D. Vigabatrin", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Vigabatrin</p>\n<p><strong>:</strong></p><p>GABA transaminase inhibitor Used for partial seizures As orphan status for infantile spasms Infantile spasms due to tuberous sclerosis were particularly responsive to vigabatrin. Progressive and permanent bilateral vision loss occurs with vigabatrin. It is not used even though it is highly effective in infantile spasms. It is reserved in resistant cases.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: A. Lamotrigine i s a prescription medicine that controls and prevents epilepsy (seizures), mania, and bipolar disorder. It is also used alone or with other similar medicines to treat neuropathic pain. Option: B. Topiramate is a medicine used to treat epilepsy (seizures) and prevent migraines. It is also used to treat Lennox-Gastaut syndrome (a rare but severe form of epilepsy that starts in early childhood). Option: C. ACTH is a hormone produced in the pituitary gland in the brain that regulates levels of cortisol and other hormones in the body</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "The following statements are true about phenytoin and fosphenytoin except:", "options": [{"label": "A", "text": "Fosphenytoin Given slow iv infusion to prevent arrhythmias, CV collapse, and coma", "correct": false}, {"label": "B", "text": "Fosphenytoin is a prodrug and is converted into phenytoin", "correct": false}, {"label": "C", "text": "Phenytoin can be given in both saline and glucose", "correct": true}, {"label": "D", "text": "Therapeutic plasma concentration of phenytoin is 10-20 Âµg/ml", "correct": false}], "correct_answer": "C. Phenytoin can be given in both saline and glucose", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Phenytoin can be given in both saline and glucose</p>\n<p><strong>:</strong></p><p>Fosphenytoin is Given through slow iv infusion to prevent arrhythmias, CV collapse, and coma (ECG monitoring is necessary). Fosphenytoin is a prodrug converted into phenytoin by phosphatases in the liver and red blood cells. Remember: Fosphenytoin can be given in both saline and glucose solutions, but phenytoin gets precipitated in a glucose solution, so not given in a glucose solution. The therapeutic plasma concentration of phenytoin is 10-20 Âµg/ml</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: A. Fosphenytoin Given slow iv infusion to prevent arrhythmias, CV collapse, and coma. Option: B. Fosphenytoin is a prodrug and is converted into phenytoin. Option: D. Therapeutic plasma concentration of phenytoin is 10-20 Âµg/ml.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 32-year-old male patient named Shashi came with anxiety, tremors, increased sweating, etc. He had recently stopped ingestion of Alcohol for two days. PR: 100bpm BP:120/80mmHg The patient appears conscious and restless. The preferred drug to be given to this patient is:-", "options": [{"label": "A", "text": "Chloral hydrate", "correct": false}, {"label": "B", "text": "SSRIs", "correct": false}, {"label": "C", "text": "Benzodiazepines", "correct": true}, {"label": "D", "text": "Phenothiazines", "correct": false}], "correct_answer": "C. Benzodiazepines", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Benzodiazepines</p>\n<p><strong>:</strong></p><p>This patient has withdrawal syndrome from the sudden withdrawal of Alcohol. Benzodiazepines (chlordiazepoxide, diazepam) are the preferred drugs. Many CNS depressants like barbiturates, phenothiazines, and chloral hydrate have been used as substitution therapy.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: A . Chloral hydrate has limited sedative and hypnotic drug use. It is also a useful laboratory chemical reagent and precursor. It is derived from chloral (trichloroacetaldehyde) by adding one equivalent of water. Option: B. SSRIs are a class of drugs that are typically used as antidepressants in the treatment of major depressive disorder, anxiety disorders, and other psychological conditions. SSRIs increase the extracellular level of the neurotransmitter serotonin by limiting its reabsorption. Option: D . Phenothiazines is an organic compound with the formula S(C6H4)2NH related to the thiazine class of heterocyclic compounds. Derivatives of phenothiazine are highly bioactive and have widespread use and rich history.</p>\n<p><strong>Table:</strong></p><p>#MANTRA</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 6-year-old boy is brought to the physician because of a 2-week history of frequent episodes of unresponsiveness. During these episodes, he stares blankly, rhythmically nods his head, and does not respond to verbal stimulation for several seconds. Hyperventilation for 30 seconds precipitates an episode of unresponsiveness and head nodding that lasts for 7 seconds. He regains consciousness immediately afterward. An electroencephalogram shows 3-Hz spikes and waves. Which of the following best describes the mechanism of action of the most appropriate pharmacotherapy for this patient